News Center

Discover all of the trending news of the Ipsen Group

12 results


Agreement signed for the creation of an Algerian-French joint venture

This took place during the meeting of the Algerian-French high-level intergovernmental Committee (CIHN), at the…


Dr James A. Levine appointed President of the Fondation IPSEN

"I am delighted to accept the Presidency of the Fondation IPSEN which plays an…


Ipsen to Present at the Citi 2017 Global Healthcare Conference

David Meek, CEO will present at the Citi 2017 Global Healthcare Conference in New York…


Ipsen supports awareness of Neuroendocrine Tumors (NET) and the NET Cancer Day on November 10, 2017

NET Cancer Day, a global initiative of the International Neuroendocrine Cancer Alliance (INCA) and…

Rare diseases

Ipsen launches a website designed with patients for patients is intended for patients who have just been diagnosed or patients…


Dr Sotirios Stergiopoulos appointed as the new President of the Board of Governors of Accreditation Council for Medical Affairs (ACMA).

Dr Sotirios Stergiopoulos, Senior Vice-President & Head of Global Medical Affairs at Ipsen Bioscience, has…


Ipsen at ESMO 2017

Want to know more about the activities Ipsen is organising and data we are sharing…

Financial information

Ipsen’s First Half 2017 Financial Results

Financial Community: audio broadcast will start at 04:00 CEST Click here to access audio webcast…


Ipsen’s Investor Day

On May 11, 2017, Ipsen hosted an Investor Day during which David Meek (CEO) and…


Discover Ipsen new clinical trials section

Visit the new clinical trials section

Financial information Group

Ipsen’s 2016 Full Year Results

David Meek, CEO Aymeric Le Chatelier, Executive Vice President, Finance have been presenting Ipsen's 2016…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020